Literature DB >> 10428872

An integrated study of fibrinogen during blood coagulation.

K E Brummel1, S Butenas, K G Mann.   

Abstract

The rate of conversion of fibrinogen (Fg) to the insoluble product fibrin (Fn) is a key factor in hemostasis. We have developed methods to quantitate fibrinopeptides (FPs) and soluble and insoluble Fg/Fn products during the tissue factor induced clotting of whole blood. Significant FPA generation (>50%) occurs prior to visible clotting (4 +/- 0.2 min) coincident with factor XIII activation. At this time Fg is mostly in solution along with high molecular weight cross-linked products. Cross-linking of gamma-chains is virtually complete (5 min) prior to the release of FPB, a process that does not occur until after clot formation. FPB is detected still attached to the beta-chain throughout the time course demonstrating release of only low levels of FPB from the clot. After release of FPB a carboxypeptidase-B-like enzyme removes the carboxyl-terminal arginine resulting exclusively in des-Arg FPB by the 20-min time point. This process is inhibited by epsilon-aminocaproic acid. These results demonstrate that transglutaminase and carboxypeptidase enzymes are activated simultaneously with Fn formation. The initial clot is a composite of Fn I and Fg already displaying gamma-gamma cross-linking prior to the formation of Fn II with Bbeta-chain remaining mostly intact followed by the selective degradation of FPB to des-Arg FPB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428872     DOI: 10.1074/jbc.274.32.22862

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system.

Authors:  Sara H Bengtson; Caroline Sandén; Matthias Mörgelin; Pauline F Marx; Anders I Olin; L M Fredrik Leeb-Lundberg; Joost C M Meijers; Heiko Herwald
Journal:  J Innate Immun       Date:  2008-07-12       Impact factor: 7.349

2.  Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects.

Authors:  A Undas; B Brzezinska-Kolarz; K Brummel-Ziedins; J Musial; A Szczeklik; K G Mann
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824

3.  Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers.

Authors:  Radwa H Abou-Saleh; Simon D Connell; Robert Harrand; Ramzi A Ajjan; Michael W Mosesson; D Alastair M Smith; Peter J Grant; Robert A S Ariëns
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

4.  Impaired factor XIII activation in patients with congenital afibrinogenemia.

Authors:  Françoise Bridey; Claude Négrier; Cedric Duval; Robert Ariëns; Philippe de Moerloose; Alessandro Casini
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941

5.  Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation.

Authors:  J H Foley; S Butenas; K G Mann; K E Brummel-Ziedins
Journal:  Anal Biochem       Date:  2012-01-03       Impact factor: 3.365

6.  Utility of plasma fibrinogen in the differential diagnosis of thyrotoxicosis.

Authors:  Jie Ma; Rui Liu; Di Wu; Wei Miao; Qian Chen; Yushu Li; Haixia Guan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

7.  Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiency.

Authors:  J H Foley; L Ferris; K E Brummel-Ziedins
Journal:  Thromb Res       Date:  2012-01-13       Impact factor: 3.944

8.  Fibrinogen variant BbetaD432A has normal polymerization but does not bind knob "B".

Authors:  Sheryl R Bowley; Susan T Lord
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

9.  Vagus nerve stimulation regulates hemostasis in swine.

Authors:  Christopher J Czura; Arthur Schultz; Martin Kaipel; Anna Khadem; Jared M Huston; Valentin A Pavlov; Heinz Redl; Kevin J Tracey
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

Review 10.  Thrombin inhibitors from different animals.

Authors:  A M Tanaka-Azevedo; K Morais-Zani; R J S Torquato; A S Tanaka
Journal:  J Biomed Biotechnol       Date:  2010-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.